Medicare Does Not Cover a TENS Unit for Back Pain — and the Trial Rental Catches the Rest (E0720, E0730)

The diagnosis decides the claim before anything else does

A referral comes in for a four-lead TENS unit. The order is signed, the patient is eligible, the delivery ticket is clean. The diagnosis line says chronic low back pain. That claim is finished before it is billed.

Medicare covers TENS under two paths, and only two. The first is acute post-operative pain, limited to 30 days from the day of surgery and payable only as a rental. The second is chronic, intractable pain other than chronic low back pain. Read that second phrase slowly, because CLBP is carved out of the coverage criterion by name.

This surprises people. TENS for back pain is one of the most common uses of the device in the general market, and referring clinicians order it in good faith. But CMS looked at the evidence in 2012, decided it was not adequate, and allowed coverage only for patients enrolled in an approved clinical study under coverage with evidence development. That window closed in June 2015. Nothing replaced it.

The chronic pain path also has its own exclusion list. TENS is not considered reasonable and necessary for headache, visceral abdominal pain, pelvic pain, or temporomandibular joint pain. That list is not exhaustive, which is the part suppliers tend to miss. The LCD gives four examples of etiologies that do not respond to TENS therapy and leaves room for a reviewer to add more. If the presumed cause of the pain is not a type accepted as responding to TENS, the claim fails on criterion one before the trial rental ever starts.

The trial rental is a gate, not a formality

For chronic pain, the beneficiary has to use the unit on a trial basis for at least one month and no more than two. That period is paid as a rental. The treating practitioner has to monitor it. And before a purchase can be covered, that practitioner must determine the patient is likely to get significant therapeutic benefit from continuous use over a long period.

Suppliers who bill a purchase without a documented trial are not making a paperwork error. They are billing for something Medicare has not agreed to buy yet.

What makes this expensive is where the missing piece sits. The trial happens in your billing system. The reevaluation happens in the practitioner's chart, three to eight weeks after delivery, and nobody on your side is holding the pen. If that note never gets written, or gets written without the three things Medicare wants in it, the purchase claim has no support and the rental months you already collected are exposed on audit too.

Three items have to appear in that reevaluation: how often the patient used the unit, the typical duration of each use, and whether it worked. A note that says "patient reports improvement, continue TENS" satisfies none of them cleanly. It gives a reviewer nothing to measure.

Where TENS claims actually die

Sorted by how often we see each one survive intake and fail later:

Look at the second column. Almost every row describes a file that passes a generic intake check. The order is signed. The dates line up. The patient is eligible. The failure is always something specific to this policy that a general checklist does not ask about.

Two leads, four leads, and the sentence nobody writes

E0720 is the two-lead device. E0730 is four or more leads. A four-lead unit can be run on two leads or four depending on the pain, and Medicare knows that, which is why the LCD asks for a specific justification: if the unit is ordered for use with four leads, the medical record has to document why two leads would not meet the patient's needs.

That sentence is rarely in the chart. Referring clinicians order E0730 because it is the better device, not because they have written an argument for it. When a reviewer pulls the file, the absence of that reasoning is a clean finding.

The supply ceilings follow the lead count. Two leads allows a maximum of one unit of A4595 per month. Four leads allows two. If the patient uses the unit less than daily, billing for A4595 should drop proportionally. Lead wire replacement under A4557 more often than every 12 months is described as rarely reasonable and necessary, which in practice means a reviewer will ask why.

Rental and purchase bill differently, and the difference is easy to miss

While the unit is rented, supplies are baked into the rental allowance. Electrodes, lead wires, batteries: none of them are separately payable. Bill them anyway and you have created an overpayment on a claim that was otherwise fine.

If the unit is purchased, the purchase allowance is all-inclusive of lead wires and one month of supplies such as electrodes, conductive gel if needed, and batteries. Separate supply billing starts after that first month, not at delivery.

The conductive garment E0731 is its own small trap. It is covered only rarely, and only when one of four narrow conditions is met, such as too many sites to stimulate for conventional electrodes to be feasible, sites that cannot be reached conventionally, a documented skin condition that prevents adhesive electrodes, or stimulation required beneath a cast. During the trial period a conductive garment is not covered at all unless the patient had a documented skin problem before the trial started and the TENS itself is reasonable and necessary.

What intake should confirm before a TENS unit ships

Why this one keeps getting through

TENS is a low-dollar item. A coordinator processing 80 files a day is not going to stop a four hundred dollar rental to argue about a diagnosis code, especially when the referring clinician is a good referral source and the patient is in pain. So it ships, and the denial arrives six weeks later, and by then the reevaluation window has closed and there is nothing to appeal with.

The volume is what makes it matter. Suppliers who take TENS referrals take a lot of them, and a policy this specific means a steady percentage of them were never payable. That percentage does not show up as a crisis. It shows up as a line in your write-offs that has been the same size for two years.

The fix is not more training. Your coordinators already know the device. The fix is a validation step that reads the diagnosis, the duration, the treatment history, and the lead count against this specific LCD before the unit leaves the warehouse, on every file, without anyone having to remember to do it.